Nanoscope Therapeutics to Participate in the 28th Annual H.C. Wainwright Global Investment Conference

Wait 5 sec.

Sulagna Bhattacharya, Chief Executive Officer, to deliver corporate presentation on Monday, September 14, 2026 NEW YORK, Sept. 11, 2026 /PRNewswire/ -- New York, September 11, 2026 — Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel,...